Dr. Grendell’s clinical interests include abdominal disorders, celiac disease, Crohn’s disease, inflammatory bowel disease, esophagitis and pancreatic diseases, among many others. He helped conduct a Phase II clinical trial that examined immunotherapy treatments’ effectiveness on stomach cancer patients.
Dr. Grendell earned his medical degree from the Ohio State University College of Medicine and Public Health in Columbus and completed his residency at Beth Israel Deaconess Medical Center in Boston. He also underwent a fellowship at the University of California in San Francisco.
More articles on GI & endoscopy:
Olympus introduces new single use aspiration needle: 4 notes
Unsafe injection practices lead to HCV outbreak, clinic closure: 4 insights
4 key points on Mercy Health-Fairfield Hospital’s $14M plan to improve inpatient & outpatient endoscopy services
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
